Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316139 | SCV000847736 | benign | Inborn genetic diseases | 2019-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000872749 | SCV001014614 | likely benign | KBG syndrome | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001637117 | SCV001849367 | benign | not provided | 2019-04-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000872749 | SCV002524211 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001637117 | SCV004143521 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | ANKRD11: BS1 |